RBM's Management Team

Click on a team member to see full bio and contact info.

Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services.  RBM’s internally developed and manufactured immunoassay kits based on Multi-Analyte Profiling (MAP) and ultrasensitive Single-Molecule Array (SimoaTM) technology, provide reproducible and quantitative data for hundreds of human proteins.  

To see the Q2 Solution’s Management Team please click here.

James P. Mapes, Ph.D.

James P. Mapes, Ph.D.

Sr. Vice President, Chief Scientific Officer

Sam LaBrie, VP Corporate Development

Samuel T. LaBrie, Ph.D.

Sr. Vice President, Corporate Development

Dominic Eisinger, Ph.D.

Dominic Eisinger, Ph.D.

Vice President, Sales & Marketing

Karri Ballard, Senior Director Clinical Research

Karri Ballard, Ph.D.

Sr. Director, Clinical Research

Dennis Denton, VP IS Technology

Dennis Denton

Vice President, Information Systems & Technology

Kelley Nitka Ph.D.

Kelley Nitka, Ph.D., HCLD

Sr. Director of Lab Operations

Josh Kemp, Senior Director Lab Operations

Joshua L. Kemp

Sr. Director, Research and Development